This list is an analysis based on recent market events. It's not an investment recommendation.
About
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
The current price of ALZCUR-BTA.ST is SEK6.10 SEK — it has decreased by -3.17% in the past 24 hours. Watch AlzeCure Pharma AB stock price performance more closely on the chart.
What is AlzeCure Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange AlzeCure Pharma AB stocks are traded under the ticker ALZCUR-BTA.ST.
What is AlzeCure Pharma AB market cap?▼
Today AlzeCure Pharma AB has the market capitalization of 700.98M
When is the next AlzeCure Pharma AB earnings date?▼
AlzeCure Pharma AB is going to release the next earnings report on November 11, 2026.
What is AlzeCure Pharma AB revenue for the last year?▼
AlzeCure Pharma AB revenue for the last year amounts to 0 SEK.
What is AlzeCure Pharma AB net income for the last year?▼
ALZCUR-BTA.ST net income for the last year is -47.65M SEK.
How many employees does AlzeCure Pharma AB have?▼
As of October 5, 2026, the company has 10 employees.
In which sector is AlzeCure Pharma AB located?▼
AlzeCure Pharma AB operates in the Health & Wellness sector.
When did AlzeCure Pharma AB complete a stock split?▼
AlzeCure Pharma AB has not had any recent stock splits.
Where is AlzeCure Pharma AB headquartered?▼
AlzeCure Pharma AB is headquartered in Huddinge, Sweden.